These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29512887)

  • 41. Drugs of abuse and the brain.
    Leshner AI; Koob GF
    Proc Assoc Am Physicians; 1999; 111(2):99-108. PubMed ID: 10220804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endocannabinoid signaling system and brain reward: emphasis on dopamine.
    Gardner EL
    Pharmacol Biochem Behav; 2005 Jun; 81(2):263-84. PubMed ID: 15936806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microglia disrupt mesolimbic reward circuitry in chronic pain.
    Taylor AM; Castonguay A; Taylor AJ; Murphy NP; Ghogha A; Cook C; Xue L; Olmstead MC; De Koninck Y; Evans CJ; Cahill CM
    J Neurosci; 2015 Jun; 35(22):8442-50. PubMed ID: 26041913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Medial Prefrontal Cortex Shapes Dopamine Reward Prediction Errors under State Uncertainty.
    Starkweather CK; Gershman SJ; Uchida N
    Neuron; 2018 May; 98(3):616-629.e6. PubMed ID: 29656872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine and serotonin metabolism associated with morphine reward and its inhibition with buspirone: A study in the rat striatum.
    Haleem DJ; Nawaz S; Salman T
    Pharmacol Biochem Behav; 2018 Jul; 170():71-78. PubMed ID: 29782941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Role of endogenous cannabinoids in cerebral reward mechanisms].
    Wenger T; Fürst S
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):26-9. PubMed ID: 15125311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic changes in dopaminergic neurotransmission induced by a low concentration of bisphenol-A in neurones and astrocytes.
    Miyatake M; Miyagawa K; Mizuo K; Narita M; Suzuki T
    J Neuroendocrinol; 2006 Jun; 18(6):434-44. PubMed ID: 16684133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release.
    Chartoff EH; Ebner SR; Sparrow A; Potter D; Baker PM; Ragozzino ME; Roitman MF
    Neuropsychopharmacology; 2016 Mar; 41(4):989-1002. PubMed ID: 26239494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine Prediction Errors in Reward Learning and Addiction: From Theory to Neural Circuitry.
    Keiflin R; Janak PH
    Neuron; 2015 Oct; 88(2):247-63. PubMed ID: 26494275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward.
    Zhao ZQ; Gao YJ; Sun YG; Zhao CS; Gereau RW; Chen ZF
    Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14519-24. PubMed ID: 17724336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contributions of dopaminergic and non-dopaminergic neurons to VTA-stimulation induced neurovascular responses in brain reward circuits.
    Brocka M; Helbing C; Vincenz D; Scherf T; Montag D; Goldschmidt J; Angenstein F; Lippert M
    Neuroimage; 2018 Aug; 177():88-97. PubMed ID: 29723641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reward deficiency syndrome: genetic aspects of behavioral disorders.
    Comings DE; Blum K
    Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inputs from the basolateral amygdala to the nucleus accumbens shell control opiate reward magnitude via differential dopamine D1 or D2 receptor transmission.
    Lintas A; Chi N; Lauzon NM; Bishop SF; Sun N; Tan H; Laviolette SR
    Eur J Neurosci; 2012 Jan; 35(2):279-90. PubMed ID: 22236063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions between opioids and anabolic androgenic steroids: implications for the development of addictive behavior.
    Nyberg F; Hallberg M
    Int Rev Neurobiol; 2012; 102():189-206. PubMed ID: 22748831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Shared Behavioral and Neurocircuitry Disruptions in Drug Addiction, Obesity, and Binge Eating Disorder: Focus on Group I mGluRs in the Mesolimbic Dopamine Pathway.
    Yohn SE; Galbraith J; Calipari ES; Conn PJ
    ACS Chem Neurosci; 2019 May; 10(5):2125-2143. PubMed ID: 30933466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of the highly selective and nonpeptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice.
    Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
    J Pharmacol Exp Ther; 1996 Oct; 279(1):177-85. PubMed ID: 8858991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neural mechanisms of the reinforcing action of cocaine.
    Wise RA
    NIDA Res Monogr; 1984; 50():15-33. PubMed ID: 6440023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of cannabinoid receptor in the brain as it relates to drug reward.
    Yamamoto T; Takada K
    Jpn J Pharmacol; 2000 Nov; 84(3):229-36. PubMed ID: 11138722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Neurobiology of opioid dependence].
    Scherbaum N; Bonnet U
    Anaesthesist; 2019 Mar; 68(3):179-190. PubMed ID: 30840108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circadian clock genes: effects on dopamine, reward and addiction.
    Parekh PK; Ozburn AR; McClung CA
    Alcohol; 2015 Jun; 49(4):341-9. PubMed ID: 25641765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.